Gene · 4017
Papers2,536
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,536
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The serum soluble scavenger with 5 domains levels: A novel biomarker for individuals with heart failure. | Front Physiol | 2023 | 37123263 | PubTator, text mining | PubMed |
| Basic Pathogenic Mechanisms and Epigenetic Players Promoted by Extracellular Vesicles in Vascular Damage. | Int J Mol Sci | 2023 | 37108672 | PubTator, text mining | PubMed |
| An Insight into the Arising Role of MicroRNAs in Hepatocellular Carcinoma: Future Diagnostic and Therapeutic Approaches. | Int J Mol Sci | 2023 | 37108330 | PubTator, text mining | PubMed |
| A Comprehensive Pan-Cancer Analysis of the Regulation and Prognostic Effect of Coat Complex Subunit Zeta 1. | Genes (Basel) | 2023 | 37107648 | PubTator, text mining | PubMed |
| The functional and evolutionary impacts of human-specific deletions in conserved elements. | Science | 2023 | 37104592 | PubTator, text mining | PubMed |
| Lysyl oxidase-like 4 exerts an atypical role in breast cancer progression that is dependent on the enzymatic activity that targets the cell-surface annexin A2. | Front Oncol | 2023 | 37091157 | PubTator, text mining | PubMed |
| LOXL2: A potential therapeutic target in the treatment of hepatocellular carcinoma? | Dig Liver Dis | 2023 | 37088591 | PubTator, text mining | PubMed |
| A novel anoikis-related gene signature to predict the prognosis, immune infiltration, and therapeutic outcome of lung adenocarcinoma. | J Thorac Dis | 2023 | 37065587 | PubTator, text mining | PubMed |
| Inhibition of N-glycosylation by glucosamine hydrochloride inhibits TGF-β1-induced LOXL2 secretion. | J Cell Biochem | 2023 | 37062903 | PubTator, text mining | PubMed |
| Cellular resistance mechanisms in cancer and the new approaches to overcome resistance mechanisms chemotherapy. | Saudi Med J | 2023 | 37062547 | PubTator, text mining | PubMed |
| Pancreatic cancer: Advances and challenges. | Cell | 2023 | 37059070 | PubTator, text mining | PubMed |
| Dihydroartemisinin Potentiates VEGFR-TKIs Antitumorigenic Effect on Osteosarcoma by Regulating Loxl2/VEGFA Expression and Lipid Metabolism Pathway. | J Cancer | 2023 | 37056396 | PubTator, text mining | PubMed |
| Frontier Review of the Molecular Mechanisms and Current Approaches of Stem Cell-Derived Exosomes. | Cells | 2023 | 37048091 | PubTator, text mining | PubMed |
| Multifunctional Lysyl Oxidases. | Int J Mol Sci | 2023 | 37047014 | PubTator, text mining | PubMed |
| The Matrix Reloaded-The Role of the Extracellular Matrix in Cancer. | Cancers (Basel) | 2023 | 37046716 | PubTator, text mining | PubMed |
| Fibroblasts as Turned Agents in Cancer Progression. | Cancers (Basel) | 2023 | 37046676 | PubTator, text mining | PubMed |
| Pancreatic cancer and fibrosis: Targeting metabolic reprogramming and crosstalk of cancer-associated fibroblasts in the tumor microenvironment. | Front Immunol | 2023 | 37033960 | PubTator, text mining | PubMed |
| Lysyl oxidase-like 2 processing by factor Xa modulates its activity and substrate preference. | Commun Biol | 2023 | 37029269 | PubTator, text mining | PubMed |
| Integrative pan-cancer analysis of cuproplasia-associated genes for the genomic and clinical characterization of 33 tumors. | Chin Med J (Engl) | 2023 | 37027423 | PubTator, text mining | PubMed |
| Sex-dependent variation in cartilage adaptation: from degeneration to regeneration. | Biol Sex Differ | 2023 | 37024929 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4017/papers?page=21